Corrigendum to “Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation”: [Annals of Oncology 28 (2017):2503–2510, (S0923753419349440), (10.1093/annonc/mdx340)]
H. Takamatsu*, N. Takezako, J. Zheng, M. Moorhead, V. E.H. Carlton, K. A. Kong, R. Murata, S. Ito, T. Miyamoto, K. Yokoyama, K. Matsue, T. Sato, T. Kurokawa, H. Yagi, Y. Terasaki, K. Ohata, M. Matsumoto, T. Yoshida, M. Faham, S. Nakao
*この論文の責任著者
研究成果: ジャーナルへの寄稿 › コメント/討論